ClinicalTrials.Veeva

Menu

Calprotectin in Chronic Prosthetic Joint Infection

T

Technical University of Munich

Status

Enrolling

Conditions

Prosthetic Joint Infection
Prosthetic Infection
Arthroplasty Complications

Treatments

Diagnostic Test: Calprotectin Lateral Flow Test

Study type

Observational

Funder types

Other

Identifiers

NCT05060952
26/19 S-SR

Details and patient eligibility

About

A bacterial infection of an artificial joint is a serious complication that often requires additional surgery to exchange the arthroplasty. It is also difficult to recognize an infected joint, as the symptoms caused by the infection are very similar to those of other problems with arthroplasties, such as loosening of the implant. To improve the ability to diagnose prosthetic joint infections, this study compares the levels of calprotectin, a specific inflammatory protein, in the joint fluid of infected joints and joints with other complications. The underlying hypothesis is that the level of calprotectin in infected joints is significantly higher, thus facilitating the diagnosis of prosthetic joint infection.

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • scheduled arthroplasty exchange for any of the following reasons:
  • infection
  • loosening
  • instability
  • malalignment
  • periprosthetic fracture

Exclusion criteria

  • acute prosthetic joint infection

Trial design

500 participants in 2 patient groups

PJI
Description:
Patients with septic arthroplasty failure
Treatment:
Diagnostic Test: Calprotectin Lateral Flow Test
Aseptic
Description:
Patients with aseptic causes of arthroplasty failure
Treatment:
Diagnostic Test: Calprotectin Lateral Flow Test

Trial contacts and locations

1

Loading...

Central trial contact

Christian Suren, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems